SEC Form 4 · accession 0001144204-18-014484
INNOVATE BIOPHARMACEUTICALS, INC. · INNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Lewis Olert
Officer — Former CFO
Period of report
Jan 25, 2018
Accepted (ET)
Mar 13, 2018 · 9:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001551986
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 25, 2018 | A | 10,000 | $0.00 | A | 70,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares of restricted common stock granted under Issuer's 2012 Omnibus Incentive Plan.